Emma can recognise patterns within complex code. James can develop several different solutions when faced with complicated problems. But it is unlikely either will find a job where they can put their…




Emma can recognise patterns within complex code. James can develop several different solutions when faced with complicated problems. But it is unlikely either will find a job where they can put their…


Eighteen months into the pandemic, monoclonal antibodies remain the only FDA-authorized outpatient treatment for patients with symptomatic COVID-19. Laboratory-made proteins that mimic the immune system’s ability to target and block the virus that causes COVID-19 from…


Researchers from The University of Texas Health Science Center at San Antonio and the South Texas Veterans Health Care System have unveiled a novel concept, “immunologic resilience,” to accurately predict which COVID-19…


Long commute times and household crowding may be good predictors for a higher number of transmissible coronavirus cases in metropolitan settings, according to Cornell urban planning, architectural and public health researchers, in…
Scientists affiliated with the Center for Innovation in Biodiversity and Drug Discovery (CIBFar), in Brazil, have discovered details of the process of maturation of 3CL, the main protease involved in replication of…


Marijuana use continued to rise among college students over the past five years and remained at historically high levels among same-aged peers who are not in college in 2020, according to survey results from the 2020 Monitoring the Future (MTF) panel study. This…
West Virginia University researcher Judith Feinberg has partnered with colleagues at Yale University to integrate services for opioid use disorder, the hepatitis C virus and HIV in 20 primary care clinics across West Virginia. The…


With the emergence of new SARS-CoV-2 variants such as beta and delta, people are not only getting a refresher course on the Greek alphabet, but also experiencing confusion and anxiety about what…


The study used a Phenome-wide (PheWAS) analysis in up to 400,000 European ancestry individuals, derived from the UK Biobank, researchers aimed to identify traits and diseases associated with COVID-19 susceptibility and severity.…